QUINN JAMES W

Director Quinn James W sold 13,444 shares of AGX at $269.12 on 2025-09-30; stock now at $279.62 after recent +22.5% surge.

Director Quinn James W sold 13,444 shares at $269.12 on 2025-09-30, reducing his holdings by -21.3% from 63,014 to 49,570 shares. The stock has since appreciated to $279.62 (+0.0% from the 52-week high of $279.62), having gained +22.5% over 30 days and +32.5% over 90 days following the sale—indicating the sale was poorly timed relative to subsequent price appreciation. His same-ticker history at AGX shows only 1 of 3 measurable prior sells were well-timed at the 90-day mark (50% accuracy); his broader cross-ticker track record shows a 33.33% well-timed rate on 5 prior sells with an average 90d return of +40.5%, suggesting a mixed record of sell timing. The company's fundamentals remain strong with annual revenue growth of +52.5% and a P/E of 32.94, offering limited context for valuation-driven motivation behind the sale.

Director Quinn James W sold all 16,557 shares (16.6K) for $4,310,475.81 in two transactions, exiting position entirely.

Director James W. Quinn completely liquidated his shareholding at Argan Inc in two separate sales on 2025-09-19 and 2025-09-22, totaling 16,557 shares (16.6K shares) for $4,310,475.81 at a blended average price of $260.34. This full exit occurs as the stock trades at $268.34, near its 52-week high of $268.34, having appreciated 20.8% over the prior 30 days and 25.0% over 90 days. Reviewing his same-ticker history at AGX, Quinn's prior three sales included two well-timed positions (90-day declines of -2.0% and realized gains of +60.4% and +63.2% respectively), though his June 2025 sale showed minimal near-term strength (+0.3% 30d, -2.0% 90d). The complete liquidation removes insider skin-in-the-game at a company with strong fundamentals: $237.7M revenue, +52.5% annual revenue growth, $35.3M net income, and a $3.7B market cap, though the 31.61 P/E suggests the stock is priced at a premium valuation.

Director James W Quinn sells 40,000 AGX shares (-70.7% of holdings) for $8.3M; stock up 31.5% in 30 days, 97.6% in 90 days post-trade.

Quinn sold 40,000 shares at $207.92 on 2025-06-10, reducing his stake from 56,557 to 16,557 shares. The sale represents a substantial reduction of his holdings despite AGX stock posting strong momentum: the stock has appreciated 31.5% over 30 days and 97.6% over 90 days since the sale, trading at $224.31 as of the current date. His prior sales at AGX (in 2024-09) similarly occurred before sustained upside: the 2024-09-10 sale saw 90-day gains of 63.2%, and the 2024-09-11 sale saw 90-day gains of 60.4%. The fundamental backdrop shows material revenue growth of 52.5% year-over-year and net income of $22,550,000, though the stock trades at a P/E of 30.56. The pattern suggests sales that, in hindsight, exited ahead of significant gains, not before declines—a timing outcome that differs from optimal sell-side positioning across both his same-ticker history and his broader cross-ticker track record (which shows 0% well-timed rate on sells).

Director Quinn James W sells 20,000 shares ($1.8M) in 2 transactions at $89.25 avg, reducing stake 24.9%.

Director Quinn James W executed two separate sales totaling 20,000 shares for $1,785,000.00 on 2024-09-10 and 2024-09-11 at blended average price $89.25. The sale reduces his holdings from 80.4K to 60.4K shares, a 24.9% reduction in his pre-transaction stake. The stock is trading near its 52-week highs ($88.79 current price versus $93.39 high) and has appreciated +27.9% over the past 30 days and +15.8% over 90 days, suggesting he divested during a period of strong recent performance. AGX fundamentals show robust growth with annual revenue growth of +26.0%, latest quarterly revenue of $227.0M, and a P/E of 27.49.